Taisho Pharmaceutical Holdings Co., Ltd.
TAISF · OTC
3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | |
|---|---|---|---|---|
| Market Cap | $452,880 | $442,883 | $592,997 | $510,488 |
| - Cash | $255,966 | $265,049 | $250,178 | $223,814 |
| + Debt | $2,590 | $3,503 | $2,591 | $3,106 |
| Enterprise Value | $199,504 | $181,337 | $345,410 | $289,780 |
| Revenue | $301,381 | $268,203 | $282,037 | $288,720 |
| % Growth | 12.4% | -4.9% | -2.3% | – |
| Gross Profit | $177,850 | $163,832 | $175,987 | $180,383 |
| % Margin | 59% | 61.1% | 62.4% | 62.5% |
| EBITDA | $54,315 | $44,642 | $45,173 | $41,824 |
| % Margin | 18% | 16.6% | 16% | 14.5% |
| Net Income | $18,997 | $13,122 | $13,316 | $20,172 |
| % Margin | 6.3% | 4.9% | 4.7% | 7% |
| EPS Diluted | 231.42 | 160.93 | 166.63 | 252.44 |
| % Growth | 43.8% | -3.4% | -34% | – |
| Operating Cash Flow | $40,972 | $28,506 | $42,026 | $41,992 |
| Capital Expenditures | -$50,379 | -$14,389 | -$14,372 | -$9,121 |
| Free Cash Flow | -$9,407 | $14,117 | $27,654 | $32,871 |